(a) For purposes of sections 246.71 to 246.722 , whenever the state-operated treatment program is required to seek consent, the state-operated treatment program shall obtain consent from a patient or a patient's representative consistent with other law applicable to consent.
(b) Consent is not required if the state-operated treatment program has made reasonable efforts to obtain the representative's consent and consent cannot be obtained within 24 hours of a significant exposure.
(c) If testing of available blood occurs without consent because the patient is unconscious or unable to provide consent, and a representative cannot be located, the state-operated treatment program shall provide the information required in section 246.712 to the patient or representative whenever it is possible to do so.
(d) If a patient dies before an opportunity to consent to blood collection or testing under sections 246.71 to 246.722 , the state-operated treatment program does not need consent of the patient's representative for purposes of sections 246.71 to 246.722 .